Concepedia

Publication | Open Access

Vandetanib Improves Anti-Tumor Effects of L19mTNFα in Xenograft Models of Esophageal Cancer

18

Citations

27

References

2010

Year

Abstract

These findings indicate that a combination of vascular damaging agents with anti-angiogenic drugs could represent a promising therapeutic strategy for esophageal cancer.

References

YearCitations

Page 1